Clincosm LogoSign in Get a demo

purpura, thrombotic thrombocytopenic

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Purpura, Thrombotic Thrombocytopenic Trial in London (IdeS (0.25 mg/kg), IdeS (0.50 mg/kg))

Terminated
Has Results
  • Purpura, Thrombotic Thrombocytopenic
  • IdeS (0.25 mg/kg)
  • IdeS (0.50 mg/kg)
  • London, Greater London, United Kingdom
    University College London Hospitals NHS
Sep 12, 2019

Purpura, Thrombotic Thrombocytopenic, TTP Trial in Seattle (N-Acetylcysteine)

Completed
  • Purpura, Thrombotic Thrombocytopenic
  • TTP
  • Seattle, Washington
    Puget Sound Blood Center
Sep 18, 2017

Purpura, Thrombotic Thrombocytopenic, Hemolytic Uremic Syndrome Trial in London (Plasma Exchange)

Withdrawn
  • Purpura, Thrombotic Thrombocytopenic
  • Hemolytic Uremic Syndrome
  • Plasma Exchange
  • London, Ontario, Canada
    Central Facility
Apr 16, 2013

Purpura, Thrombotic Thrombocytopenic Trial (Octaplas infusion and (group 1), Octaplas infusion and (group 2))

Withdrawn
  • Purpura, Thrombotic Thrombocytopenic
  • Octaplas infusion and placebo (group 1)
  • Octaplas infusion and placebo (group 2)
  • (no location specified)
Dec 18, 2012

Purpura, Thrombotic Thrombocytopenic, Von Willebrand Disease Type-2b Trial in Vienna (ARC1779)

Completed
  • Purpura, Thrombotic Thrombocytopenic
  • Von Willebrand Disease Type-2b
  • Vienna, Austria
    Archemix Investigational Site
Jan 8, 2009